Role of endothelium-related mechanisms in the pathophysiology of renal ischemia/reperfusion in normal rabbits

被引:62
作者
Caramelo, C
Espinosa, G
Manzarbeitia, F
Cernadas, MR
Tejerizo, GP
Tan, D
Mosquera, JR
Digiuni, E
Monton, M
Millas, I
Hernando, L
Casado, S
LopezFarre, A
机构
[1] UNIV AUTONOMA MADRID,FDN JIMENEZ DIAZ,LAB NEFROL & HIPERTENS,MADRID 28040,SPAIN
[2] FED UNIV RIO DE JANEIRO,BR-21941 RIO JANEIRO,BRAZIL
[3] HOSP MOSTOLES,MADRID,SPAIN
关键词
L-arginine; superoxide dismutase; neutrophil; nitric oxide;
D O I
10.1161/01.RES.79.5.1031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study addressed the effect of interventions aimed to increase NO in the setting of acute renal ischemia/reperfusion (I/R) in uninephrectomized rabbits. In the 60-minute post-Im period, L-arginine+superoxide (O-2(.-)) dismutase (SOD) synergistically improved the renal functional(69.4% versus 10.4% of the pre-I/R glomerular filtration rate with or without L-arginine+SOD, respectively; P < .01) and histological parameters (82.9% decrease of medullary congestion in L-arginine+SOD, P < .01 versus vehicle) and blocked the I/R-dependent neutrophil accumulation (89.3% reduction). In spite of these results over the short term, a second set of experiments disclosed that the protection by L-arginine+SOD was no longer present at 24 and 48 hours (plasma creatinine in vehicle-treated versus L-arginine + SOD-treated animals [mg/100 mL]: 24 hours after I/R, 9.1 +/- 1.9 versus 8.07 +/- 0.65; 48 hours after I/R, 11.6 +/- 3.6 versus 9.7 +/- 0.9; P = NS in all the cases). Additional experiments were conducted using a milder 30-minute ischemic model, which showed no significant functional or histological protection by using L-arginine+SOD. In conclusion, our experiments disclosed the following: (1) the critical importance of the interaction between NO and O-2(.-) in the acute protective effect of L-arginine (this effect not only improved renal function and histology but also reduced neutrophil accumulation) and (2) the discordance existing between the immediate protection afforded by L-arginine+SOD and the lack of protection observed at 24 and 48 hours. This finding suggests that a punctual intervention on the NO system at the time of I/R is not sufficient to reduce renal damage over the long term.
引用
收藏
页码:1031 / 1038
页数:8
相关论文
共 50 条
[1]  
ATANASOVA I, 1992, Journal of the American Society of Nephrology, V3, P539
[2]   OXYGEN FREE-RADICAL INDUCED DAMAGE IN KIDNEYS SUBJECTED TO WARM ISCHEMIA AND REPERFUSION - PROTECTIVE EFFECT OF SUPEROXIDE-DISMUTASE [J].
BAKER, GL ;
CORRY, RJ ;
AUTOR, AP .
ANNALS OF SURGERY, 1985, 202 (05) :628-641
[3]   APPARENT HYDROXYL RADICAL PRODUCTION BY PEROXYNITRITE - IMPLICATIONS FOR ENDOTHELIAL INJURY FROM NITRIC-OXIDE AND SUPEROXIDE [J].
BECKMAN, JS ;
BECKMAN, TW ;
CHEN, J ;
MARSHALL, PA ;
FREEMAN, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) :1620-1624
[4]   ISCHEMIC ACUTE RENAL-FAILURE AND ANTIOXIDANT THERAPY IN THE RAT - THE RELATION BETWEEN GLOMERULAR AND TUBULAR DYSFUNCTION [J].
BIRD, JE ;
MILHOAN, K ;
WILSON, CB ;
YOUNG, SG ;
MUNDY, CA ;
PARTHASARATHY, S ;
BLANTZ, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (05) :1630-1638
[5]   MECHANISMS OF ISCHEMIC ACUTE-RENAL-FAILURE [J].
BONVENTRE, JV .
KIDNEY INTERNATIONAL, 1993, 43 (05) :1160-1178
[6]   MEASUREMENT OF CUTANEOUS INFLAMMATION - ESTIMATION OF NEUTROPHIL CONTENT WITH AN ENZYME MARKER [J].
BRADLEY, PP ;
PRIEBAT, DA ;
CHRISTENSEN, RD ;
ROTHSTEIN, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1982, 78 (03) :206-209
[7]   PROTECTIVE EFFECT OF INTRARENAL CALCIUM MEMBRANE BLOCKERS BEFORE OR AFTER RENAL ISCHEMIA - FUNCTIONAL, MORPHOLOGICAL, AND MITOCHONDRIAL STUDIES [J].
BURKE, TJ ;
ARNOLD, PE ;
GORDON, JA ;
BULGER, RE ;
DOBYAN, DC ;
SCHRIER, RW .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (05) :1830-1841
[8]   NO, NITROSONIUM IONS, NITROXIDE IONS, NITROSOTHIOLS AND IRON-NITROSYLS IN BIOLOGY - A CHEMISTS PERSPECTIVE [J].
BUTLER, AR ;
FLITNEY, FW ;
WILLIAMS, DLH .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (01) :18-22
[9]  
CERNADAS MR, 1992, J PHARMACOL EXP THER, V263, P1923
[10]  
CHINTALA MS, 1993, N-S ARCH PHARMACOL, V348, P305